Stage IV Urethral Cancer
4 clinical trials · Condition
◉ Watch Stage IV Urethral Cancer
| Record | Firm | Date |
|---|---|---|
| Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172) | University of Chicago | 2017-09-13 |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer (NCT02437370) | University of California, Davis | 2015-09-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
Track Stage IV Urethral Cancer automatically
Every clearance here is in the API, with alerts when new ones post.